ST-1891

N/A

Report date: 2024/08/16 15:21:30

Base Information

Drug NameST-1891
Drug Alias NameST-1891
ClassificationBiologics
Mechanisms of ActionParathyroid hormone replacements
TargetsParathyroid hormone receptor
Therapy Area/IndicationsHypothyroidism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSention Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesSention Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsHypothyroidism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A